Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Meridian Bioscience

(NASDAQ: VIVO)
Add to Portfolio
-0.11 (-1.39%)
as of Feb 18, 2020

Last 7.79
Change -0.11 (-1.39%)
Open 7.90
Prev. Close 7.90
Today's Range
7.77
7.99
52wk Range
7.62
17.71
Volume 420,100
Avg Volume 699,885
Sector SIC-2835 In Vitro & In Vivo Diagnostic Substances

Perfomance Comparison

Name Today 3-Month 1-Year
VIVO -1.39% -14.30% -52.99%
DJIA -0.56% +5.72% +12.94%
S&P 500 -0.29% +8.27% +21.43%

Key Statistics

Annual EPS 0.46
Dividend Yield 0.00%
P/E Ratio 13.91
Market Capitalization, $K 345,630
Weighted Alpha -49.50
Standard Deviation -0.23
Profit Margin 16.53%
Beta 0.44

Growth Rates

YTD -20.27%
1-Year -52.32%
3-Year -38.04%
5-Year -59.15%
10-Year -64.35%

Opinion

Sell Hold Buy

Recent Headlines

Meridian Bioscience (VIVO) Beats Q1 Earnings Estimates

ZACKS - Fri Feb 07, 08:45AM EST
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 66.67% and -2.64%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?(full story)
VIVO: 7.79 (-0.11)

Meridian Bioscience Reports First Quarter Fiscal 2020

GlobeNewswire via COMTEX - Fri Feb 07, 07:30AM EST
Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the first quarter ended December 31, 2019.(full story)
VIVO: 7.79 (-0.11)

Watch for Meridian Biosci to Potentially Rebound After

Comtex SmarTrend(R) via COMTEX - Mon Feb 03, 01:14PM EST
Meridian Biosci (NASDAQ:VIVO) traded in a range yesterday that spanned from a low of $9.51 to a high of $9.95. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $9.59 on volume of 120,000 share(full story)
VIVO: 7.79 (-0.11)

Analysts Estimate Meridian Bioscience (VIVO) to Report

ZACKS - Fri Jan 31, 12:30PM EST
Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.(full story)
VIVO: 7.79 (-0.11)

Point of Care Testing Essential for Preventing Spread

PR Newswire via COMTEX - Wed Jan 29, 10:51AM EST
In 2011, the National Academies Of Sciences, Engineering and Medicine published a report entitled: "Evaluating Systems for the Early Detection of Biological Threats (abbreviated version)". They were prophetic in saying that the in(full story)
HWKE: 0.5000 (unch), NNVC: 7.04 (-0.30), INO: 4.22 (+0.07), NVAX: 7.99 (+0.31), VIVO: 7.79 (-0.11)